These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32361566)

  • 1. HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer.
    Schroeder L; Pring M; Ingarfield K; Pawlita M; Leary SD; Thomas SJ; Waylen A; Waterboer T; Ness AR
    Oral Oncol; 2020 Aug; 107():104721. PubMed ID: 32361566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with unknown primary status in head and neck squamous cell carcinoma.
    Kalavacherla S; Li V; Voora R; Victor M; Faraji F; Guo T
    Oral Oncol; 2024 Jan; 148():106650. PubMed ID: 38039876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin.
    Yasui T; Morii E; Yamamoto Y; Yoshii T; Takenaka Y; Nakahara S; Todo T; Inohara H
    PLoS One; 2014; 9(4):e95364. PubMed ID: 24752007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
    Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
    Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Horwich P; Gundale A; Patin S; Flores J; Moore Medlin T; Chang BA; Nathan CO
    Head Neck; 2021 Sep; 43(9):2698-2704. PubMed ID: 34002904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.
    Lop J; García J; López M; Taberna M; Mena M; Alemany L; Quer M; León X
    Head Neck; 2019 May; 41(5):1328-1334. PubMed ID: 30549389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Whitmarsh A; Pring M; Thomas SJ; Waylen A; Ness AR; Dudding T; Pawlita M; Brenner N; Waterboer T; Schroeder L
    Cancer; 2021 Jul; 127(14):2442-2452. PubMed ID: 33721332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
    Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
    Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A matched comparison of human papillomavirus-induced squamous cancer of unknown primary with early oropharynx cancer.
    Ross RB; Koyfman SA; Reddy CA; Houston N; Geiger JL; Woody NM; Joshi NP; Greskovich JF; Burkey BB; Scharpf J; Lamarre ED; Prendes B; Lorenz RR; Adelstein DJ; Ward MC
    Laryngoscope; 2018 Jun; 128(6):1379-1385. PubMed ID: 29086413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
    Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
    Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling.
    Lee HP; Li CJ; Lee CC
    Head Neck; 2024 Jun; 46(6):1294-1303. PubMed ID: 38497289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of human papilloma virus and p16 in occult primary of the head and neck: a comprehensive review of the literature.
    Fotopoulos G; Pavlidis N
    Oral Oncol; 2015 Feb; 51(2):119-23. PubMed ID: 25467774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
    Menegaldo A; Schroeder L; Holzinger D; Tirelli G; Dal Cin E; Tofanelli M; Rigo S; Mantovani M; Stellin M; Del Mistro A; Dei Tos AP; Guerriero A; Niero M; Borsetto D; Da Mosto MC; Polesel J; Pawlita M; Waterboer T; Boscolo-Rizzo P
    Laryngoscope; 2021 May; 131(5):1042-1048. PubMed ID: 33103777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for human papillomavirus-positive nonoropharyngeal squamous cell carcinoma.
    Windon MJ; D'Souza G; Waterboer T; Rooper L; Westra WH; Troy T; Pardoll D; Tan M; Yavvari S; Kiess AP; Miles B; Mydlarz WK; Ha PK; Bender N; Eisele DW; Fakhry C
    Head Neck; 2020 Aug; 42(8):1954-1962. PubMed ID: 32101350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.